J&J latest pharma firm to volunteer pricing data
February 28, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …
Sanofi and Lonza partner up for €270m biologics facility
February 28, 2017Manufacturing and Production Lonza, Sanofi
Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …
Huge data loss puts NHS privatisation and Health Secretary under pressure
February 28, 2017Manufacturing and Production Jeremy Hunt, NHS, data
It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …
EMA recommends expanded indication for Janssen multiple myeloma drug
February 27, 2017Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex
The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …
La Jolla finds potential jewel in successful Phase 3 trial
February 27, 2017Manufacturing and Production, Research and Development La Jolla pharmaceutical
La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …
Moderna Therapeutics instates MIT Treasurer to Board of Directors
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics
Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …
Does Trump pose a threat to the FDA’s future?
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump
President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …
MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial
February 27, 2017Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir
MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …
Assay opens way to autoantibodies treatment for rheumatoid arthritis
February 27, 2017Research and Development, Sales and Marketing rheumatoid arthritis
A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …
Cuba begins Phase 1 testing of HIV vaccine
February 27, 2017Research and Development, Sales and Marketing Cuba, HIV
Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …
EFPIA names first female Director General
February 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA
Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …
Weight loss drug reduces diabetes risk by 80%, according to ICL research
February 27, 2017Research and Development, Sales and Marketing diabetes, icl, liraglutide
Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …
Celgene announces shock departure of COO
February 27, 2017Medical Communications, Sales and Marketing Celgene
Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …
AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation
February 24, 2017Sales and Marketing AstraZeneca, EMA
AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …
Ex-GSK SVP instated as CMO at PureTech
February 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PureTech Health
PureTech Health, a cross-disciplinary biopharmaceutical company, announced that it had appointed Atul Pande as the Chief Medical Officer. Pande had …
Top Ten most popular articles on Pharmafile.com this week
February 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and this week in pharma has seen a slew of positive clinical trial results released in Crohn’s …
Developing talent and partnership to create new medicines
February 24, 2017Medical Communications ABPI
The ABPI discusses how investing in R&D education and collaboration can reap long-term benefits to the pharmaceutical industry and the …
India’s NPPA identifies 634 non-compliant drug pricings
February 24, 2017Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa
India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …
Death in trial of Roche’s potential blockbuster haemophilia drug
February 24, 2017Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia
Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …
EFPIA names new first female Director General Nathalie Moll
February 24, 2017Business Services, Medical Communications, Sales and Marketing EFPIA, appointment
Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
